Such a trial would likely take several years and cost tens of millions of dollars, but the potential payoff, a new treatment option for a condition that affects over a billion people worldwide, justifies the investment
What to Expect from Your Plan Olivera keeps things simple and upfront
Moreover, GLP-1RAs suppress neuroinflammation in preclinical studies [101, 146], and exenatide, given either twice daily or once weekly, improved disease activity scores in people with Parkinsons disease [169, 170]
Examples include: Rheumatoid arthritis Multiple sclerosis Hashimoto's thyroiditis Lupus Psoriasis Historically autoimmune diseases have been treated with immune suppression
While compounded versions are a cheap and sometimes effective alternative to these pricey drugs, they still come with many risks
Diabetologia 2010